260 related articles for article (PubMed ID: 1338980)
21. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
Li Y; Li H; Smith-Gill SJ; Mariuzza RA
Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
[TBL] [Abstract][Full Text] [Related]
22. [Spatial structure of a Fab-fragment of a monoclonal antibody to human interleukin-2 in two crystalline forms at a resolution of 2.2 and 2.9 angstroms].
Fokin AV; Afonin PV; Mikhaĭlova IIu; Tsygannik IN; Mareeva TIu; Nesmeianov VA; Pangborn W; Lee N; Duax W; Siszak E; Pletnev VZ
Bioorg Khim; 2000 Aug; 26(8):571-8. PubMed ID: 11040993
[TBL] [Abstract][Full Text] [Related]
23. Structure of a neutralizing antibody bound monovalently to human rhinovirus 2.
Hewat EA; Marlovits TC; Blaas D
J Virol; 1998 May; 72(5):4396-402. PubMed ID: 9557730
[TBL] [Abstract][Full Text] [Related]
24. Induced pocket to accommodate the cell attachment Arg-Gly-Asp motif in a neutralizing antibody against foot-and-mouth-disease virus.
Verdaguer N; Mateu MG; Bravo J; Domingo E; Fita I
J Mol Biol; 1996 Feb; 256(2):364-76. PubMed ID: 8594203
[TBL] [Abstract][Full Text] [Related]
25. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
Covaceuszach S; Cattaneo A; Lamba D
Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
[TBL] [Abstract][Full Text] [Related]
26. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
[TBL] [Abstract][Full Text] [Related]
27. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.
Calarese DA; Scanlan CN; Zwick MB; Deechongkit S; Mimura Y; Kunert R; Zhu P; Wormald MR; Stanfield RL; Roux KH; Kelly JW; Rudd PM; Dwek RA; Katinger H; Burton DR; Wilson IA
Science; 2003 Jun; 300(5628):2065-71. PubMed ID: 12829775
[TBL] [Abstract][Full Text] [Related]
28. The three-dimensional structure of an intact monoclonal antibody for canine lymphoma.
Harris LJ; Larson SB; Hasel KW; Day J; Greenwood A; McPherson A
Nature; 1992 Nov; 360(6402):369-72. PubMed ID: 1448155
[TBL] [Abstract][Full Text] [Related]
29. Structural and functional characterization of a monoclonal antibody specific for the preS1 region of hepatitis B virus.
Pizarro JC; Vulliez-le Normand B; Riottot MM; Budkowska A; Bentley GA
FEBS Lett; 2001 Dec; 509(3):463-8. PubMed ID: 11749974
[TBL] [Abstract][Full Text] [Related]
30. Three-dimensional structure of an Fab-peptide complex: structural basis of HIV-1 protease inhibition by a monoclonal antibody.
Lescar J; Stouracova R; Riottot MM; Chitarra V; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
J Mol Biol; 1997 Apr; 267(5):1207-22. PubMed ID: 9150407
[TBL] [Abstract][Full Text] [Related]
31. Flexibility of the major antigenic loop of foot-and-mouth disease virus bound to a Fab fragment of a neutralising antibody: structure and neutralisation.
Verdaguer N; Schoehn G; Ochoa WF; Fita I; Brookes S; King A; Domingo E; Mateu MG; Stuart D; Hewat EA
Virology; 1999 Mar; 255(2):260-8. PubMed ID: 10069951
[TBL] [Abstract][Full Text] [Related]
32. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
[TBL] [Abstract][Full Text] [Related]
33. Crystal structure of human immunoglobulin fragment Fab New refined at 2.0 A resolution.
Saul FA; Poljak RJ
Proteins; 1992 Nov; 14(3):363-71. PubMed ID: 1438175
[TBL] [Abstract][Full Text] [Related]
34. Crystallization and preliminary X-ray diffraction studies of a monoclonal antibody Fab fragment against foot-and-mouth disease virus and of its complex with the main antigenic site peptide.
Verdaguer N; Mateu MG; Bravo J; Tormo J; Giralt E; Andreu D; Domingo E; Fita I
Proteins; 1994 Feb; 18(2):201-3. PubMed ID: 8159669
[TBL] [Abstract][Full Text] [Related]
35. Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.
Smith TJ; Chase ES; Schmidt TJ; Olson NH; Baker TS
Nature; 1996 Sep; 383(6598):350-4. PubMed ID: 8848050
[TBL] [Abstract][Full Text] [Related]
36. Fabs specific for 8-oxoguanine: control of DNA binding.
Bespalov IA; Bond JP; Purmal AA; Wallace SS; Melamede RJ
J Mol Biol; 1999 Nov; 293(5):1085-95. PubMed ID: 10547287
[TBL] [Abstract][Full Text] [Related]
37. Structure of the complex between the Fab fragment of a neutralizing antibody for type 1 poliovirus and its viral epitope.
Wien MW; Filman DJ; Stura EA; Guillot S; Delpeyroux F; Crainic R; Hogle JM
Nat Struct Biol; 1995 Mar; 2(3):232-43. PubMed ID: 7539711
[TBL] [Abstract][Full Text] [Related]
38. Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity.
Thompson J; Pope T; Tung JS; Chan C; Hollis G; Mark G; Johnson KS
J Mol Biol; 1996 Feb; 256(1):77-88. PubMed ID: 8609615
[TBL] [Abstract][Full Text] [Related]
39. Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody.
Smith TJ; Olson NH; Cheng RH; Liu H; Chase ES; Lee WM; Leippe DM; Mosser AG; Rueckert RR; Baker TS
J Virol; 1993 Mar; 67(3):1148-58. PubMed ID: 7679742
[TBL] [Abstract][Full Text] [Related]
40. Modeling the antigen combining site of an anti-dinitrophenyl antibody, ANO2.
Bassolino-Klimas D; Bruccoleri RE; Subramaniam S
Protein Sci; 1992 Nov; 1(11):1465-76. PubMed ID: 1303765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
